Key Takeaways & Executive Findings
- •• • WRK peptide achieves a minimum inhibitory concentration (MIC) of 4 μg mL−1 against planktonic P. acnes and a minimum biofilm eradication concentration (MBEC) of 64 μg mL−1, demonstrating potent antibacterial and antibiofilm efficacy under anaerobic conditions. • • The AMP-loaded microneedles (MNs) exhibit sufficient mechanical strength to penetrate skin, enabling effective dermal delivery of WRK peptide for localized treatment of subcutaneous P. acnes infections. • • In a mouse back acne model, AMP MN treatment significantly reduced inflammation and cleared P. acnes infection, with histological analysis showing reduced inflammatory cell infiltration and fibrous tissue hyperplasia compared to the blank MN group (skin thickness 2000–2400 μm). • • AMP MNs outperformed commercial clindamycin gel in therapeutic efficacy, offering a non-antibiotic strategy that avoids drug resistance development, a critical advantage given the >50% resistance rates of P. acnes to erythromycin and clindamycin in many regions.
Abstract
Anaerobic bacterial infections, prevalent in oxygen-deprived tissues, are recalcitrant to conventional antibiotics due to slow bacterial metabolism and the generation of nutrient-rich niches that foster polymicrobial biofilms. Propionibacterium acnes (P. acnes), a skin commensal, exemplifies this challenge, causing acne vulgaris and implant-associated infections, with rising antibiotic resistance. This study introduces an antimicrobial peptide (AMP), WRK (sequence: WRKFRRFKFRW-NH2), which induces endogenous reactive oxygen species (ROS) production in anaerobic bacteria, exploiting their inherent low ROS tolerance. WRK exhibited potent antibacterial activity, with a minimum inhibitory concentration (MIC) of 4 μg mL−1 against planktonic P. acnes and a minimum biofilm eradication concentration (MBEC) of 64 μg mL−1. To enable dermal delivery, WRK was encapsulated in layered dissolving microneedles (MNs), which demonstrated adequate mechanical strength for skin penetration. In a mouse back acne model, AMP MNs significantly reduced P. acnes infection and inflammation, outperforming commercial clindamycin gel. Histological analysis confirmed reduced inflammatory cell infiltration and tissue hyperplasia in the AMP MN group. This strategy offers a promising approach for treating anaerobic infections without promoting drug resistance, addressing a critical unmet need in clinical dermatology and implant surgery.
1. Introduction
Anaerobic bacterial infections, particularly those caused by Propionibacterium acnes, pose a significant clinical challenge due to their prevalence in oxygen-deprived environments such as chronic wounds and implant sites. The slow metabolic rate of anaerobes renders conventional antibiotics, which typically target growth-related processes, largely ineffective. Moreover, anaerobic fermentation produces small-molecule nutrients that promote polymicrobial infections, complicating treatment. The rise of antibiotic resistance, with over 50% of P. acnes strains resistant to erythromycin and clindamycin in many regions, underscores the urgent need for alternative therapeutic strategies that circumvent resistance mechanisms.
This study addresses this bottleneck by employing an antimicrobial peptide (WRK) that induces endogenous reactive oxygen species (ROS) production in anaerobic bacteria, exploiting their inherently low ROS tolerance. Unlike conventional antibiotics, this mechanism does not rely on oxygen and avoids resistance development. The peptide is delivered via dissolving microneedles, enabling targeted dermal administration. In a mouse model of back acne, the AMP microneedle system demonstrated superior efficacy compared to commercial clindamycin gel, significantly reducing bacterial load and inflammation. This approach offers a promising, resistance-free strategy for treating anaerobic infections, with potential applications in dermatology and implant-associated infections.
Loading authentic research manuscript (Pages 1–5)...
LI Kejia, CHENG Aguo, JU Xiaoyan, OU Jinzhao, WAN Chenxiao, ZHU Meng, GAO Yunhua, TIAN Ye, NIU Zhongwei (2026). Antimicrobial Peptide Microneedles with Endogenous ROS-Generating Capacity for the Treatment of Anaerobic Propionibacterium acnes Infection. SCIENCE CHINA Materials. https://doi.org/10.1007/s40843-025-3812-5
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoGreenTechare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoGreenTech claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the mechanism by which WRK peptide induces ROS generation in anaerobic bacteria, and how does this avoid resistance development?
WRK peptide interferes with glycolysis, a key metabolic pathway in anaerobic bacteria, leading to the production of endogenous ROS. Anaerobic bacteria have minimal superoxide dismutase (SOD) activity and lower redox potential in their metal centers, making them highly susceptible to ROS. This multi-targeted oxidative damage is less likely to select for resistance compared to single-target antibiotics, as it simultaneously disrupts multiple physiological processes.
What are the key performance metrics of the WRK peptide and the microneedle delivery system?
WRK peptide exhibits a minimum inhibitory concentration (MIC) of 4 μg mL−1 against planktonic P. acnes and a minimum biofilm eradication concentration (MBEC) of 64 μg mL−1. The microneedles are designed with WRK loaded at the tips and possess adequate mechanical strength to puncture the skin, as demonstrated in the mouse model. In vivo, the AMP MN group showed significantly reduced inflammation and bacterial clearance compared to the blank MN group, with skin thickness measurements indicating reduced inflammatory cell infiltration.
How does the AMP microneedle compare to commercial clindamycin gel in terms of therapeutic efficacy?
In the mouse back acne model, the AMP MN group exhibited faster elimination of P. acnes infection and milder inflammation compared to the commercial clindamycin gel group. Histological analysis (H&E staining) revealed no discernible lesions in the epidermis and reduced inflammatory cell infiltration and fibrous tissue hyperplasia in the AMP MN group, whereas the blank MN group showed substantial inflammation and skin thickness ranging from 2000 to 2400 μm.
What are the potential scalability and manufacturing considerations for translating this microneedle technology to clinical use?
The study demonstrates a layered dissolving microneedle fabrication process that loads WRK peptide at the tips. Scalability would require optimization of microneedle manufacturing to ensure consistent peptide loading and mechanical properties. The peptide synthesis and microneedle fabrication are based on established techniques, but clinical translation would necessitate Good Manufacturing Practice (GMP) compliance, stability studies, and regulatory approval. Cost-effectiveness compared to existing topical antibiotics would also be a factor, though the potential to reduce antibiotic resistance may offset higher upfront costs.
What are the limitations of this study and what further investigations are needed?
The study primarily uses a mouse back acne model, which may not fully replicate human skin conditions. Further studies should evaluate the efficacy and safety in human clinical trials, including long-term effects and potential toxicity. Additionally, the mechanism of ROS generation and its specificity to anaerobic bacteria should be further elucidated. The potential for WRK peptide to affect commensal skin microbiota also warrants investigation. Finally, the stability and release kinetics of the microneedle formulation under various storage conditions need to be characterized.
Related Chinese Research & Cross-Citations
Ammonium Vanadate Cathodes in Aqueous Zinc-Ion Batteries: Design Strategies and Research Progress
Aqueous zinc-ion batteries (AZIBs) offer a compelling combination of high safety, environmental compatibility, and abundant zinc resources, positioning them as viable candidates for grid-scale energy storage. Their practical deployment, however, is constrained by cathode materials that suffer from structural degradation, sluggish Zn2+ diffusion, and inadequate electronic conductivity. Ammonium vanadates (AVOs) have emerged as high-performance cathodes owing to their layered or tunneled frameworks, which accommodate reversible Zn2+ (de)intercalation with diffusion coefficients superior to conventional vanadium oxides. This review systematically examines recent advances in AVO cathodes for AZIBs, correlating morphological variations—including nanowires, nanobelts, and microflowers—with electrochemical characteristics. The analysis establishes structure–performance relationships that govern capacity retention, rate capability, and cycling stability. Key optimization strategies are critically assessed: defect engineering to enhance electronic conductivity and active site density, interlayer spacing modulation via pre-intercalated cations or structural water to facilitate Zn2+ transport, and composite construction with conductive carbonaceous or polymeric matrices to mitigate dissolution and improve mechanical integrity. Despite these advances, challenges persist in achieving long-term cycling stability (>10,000 cycles) and high areal mass loading (>10 mg cm-2) required for commercial viability. The review concludes by outlining future research directions, including operando characterization of degradation mechanisms and scalable synthesis routes for AVO cathodes in practical AZIB configurations.
Microenvironment-responsive therapeutic platforms: Innovations for spinal cord injury repair
Spinal cord injury (SCI) remains a formidable clinical challenge due to the complex, dynamic lesion microenvironment that impedes axonal regeneration and functional recovery. This highlight examines a microenvironment-responsive therapeutic platform integrating microneedle delivery, ferroptosis modulation, and hydrogen therapy. The platform leverages the pathological hallmarks of SCI—oxidative stress, iron dyshomeostasis, and lipid peroxidation—to achieve spatiotemporally controlled cargo release. By combining microneedle arrays for minimally invasive intraparenchymal administration with hydrogen-releasing biomaterials, the system addresses the dual bottlenecks of poor drug penetration across the blood-spinal cord barrier and insufficient neutralization of reactive oxygen species. Ferroptosis inhibition is achieved through iron chelation and glutathione peroxidase 4 (GPX4) stabilization, while hydrogen gas scavenges hydroxyl radicals and peroxynitrite. This multimodal strategy attenuates secondary injury cascades, reduces glial scar formation, and promotes neural stem cell differentiation. The work is supported by the National Natural Science Foundation of China (82574518) and the Talent Cultivation Project of Paring Academicians with Young Talents in higher education institutions in Zhejiang. The authors declare no conflict of interest. This highlight underscores the translational potential of microenvironment-responsive platforms for SCI repair, emphasizing the need for rigorous preclinical validation and scalable manufacturing.
Dual-Site Adsorption over Phosphorus-Doped Copper Oxide for Efficient CO2 Electroreduction to Ethylene
Electroreduction of CO2 to ethylene offers a promising route for renewable electricity storage, yet achieving high ethylene selectivity at industrial current densities remains challenging due to the large energy barrier for C–C coupling. Here, we report a “MOF-assisted in situ doping” strategy to introduce the oxophilic nonmetal phosphorus (P) into the copper oxide (CuO) lattice, constructing a localized Cu–P dual-site adsorption configuration for the key *OCCHO intermediate. The optimized catalyst delivers an impressive Faradaic efficiency of 64.6% for ethylene with a partial current density of 646 mA cm-2. Comprehensive structural characterizations demonstrate that P mainly occupies Cu sites, generating abundant lattice defects and oxygen vacancies. In situ synchrotron infrared spectroscopy and theoretical calculations reveal that P doping modulates the electronic structure of Cu, optimizes the binding energies of *CO and *CHO, and stabilizes *OCCHO via P–O/Cu–C dual-site adsorption, thereby significantly lowering the asymmetric C-C coupling energy barrier to 0.74 eV. This work highlights a dual-site microenvironment regulation strategy for CO2-to-ethylene electroreduction.
Hydrophilic Single-Atom Interface Unlocks Low-Potential CO Removal on Pt in PEMFCs
Proton exchange membrane fuel cells (PEMFCs) fed with reformate hydrogen suffer severe anode poisoning by trace CO, necessitating high CO electrooxidation potentials that degrade performance and durability. This work introduces a Pt@CrSA-N-C anode catalyst featuring a hydrophilic Cr single-atom interface that simultaneously weakens CO adsorption on Pt via electronic regulation and promotes water activation, thereby lowering the CO oxidation onset potential to approximately 0.13 V vs. RHE. The onset potential was determined by two independent methods: the first potential at which the background-corrected current exceeds 0 mA cm-2 during CO oxidation reaction tests in a three-electrode system, and the potential at which the forward scan current exceeds the N2 background current in CO-stripping voltammetry. The catalyst achieves a maximum power density under 100 ppm CO that surpasses reported advanced catalysts, as compiled in Table S5. Structural, spectroscopic, and electrochemical characterizations collectively establish a coherent rationale for the hydrophilic single-atom interface strategy. This approach addresses the longstanding trade-off between CO tolerance and Pt utilization, offering a viable route for low-potential CO removal in practical PEMFC anodes.
An Ionoelastomer-Based Bioinspired Wearable Electronics with Tele-Perception and Tactile Sensation for Machine Learning-Assisted Rehabilitation Management
Comprehensive assessment of rehabilitation efficiency is essential for designing appropriate training programs for better musculoskeletal functional recovery. Existing contact-receptor-dependent rehabilitation assessment systems mostly focus on assessing the restoration of muscle function by evaluating grip strength or joint flexion angle; however, parameters reflecting neuromuscular synergistic function are always overlooked. Herein, we develop an ionoelastomer-based soft artificial electroreceptor (SAER) that integrates tele-perception and tactile sensation to track the rehabilitation process, collecting signals related to approaching speed and grip strength sequentially. The SAER uses polyurethane ionoelastomer incorporated with quasi-solid conductive salt as the electric field receptor, and is integrated on a rehabilitation-training ball after assembly to establish an untethered detection device; this enables the remote capture of hand approaching parameter within a 9 cm range, followed by the quantification of grip strength when contacting and grasping. Furthermore, a data-driven assessment system is established by integrating machine learning, which accurately classifies rehabilitation efficiency into six levels; it supports for rehabilitation evaluation and training programs adjustment. Overall, the SAER-based rehabilitation management system establishes a paradigm that synergistically evaluating parameters corresponding to neuromuscular functional restoration and holds strong potential for home-based active rehabilitation for minimizing dependence on frequent clinical supervision.
Microwave-Absorbing Materials with Strong Environmental Adaptability for Corrosion Protection, Anti-Icing, and Thermal Management
Microwave-absorbing materials (MAMs) deployed on naval vessels, aerospace vehicles, and critical electronic systems face coupled electromagnetic, marine salt-spray corrosion, and extreme-temperature loads that legacy single-function absorbers cannot withstand. This review consolidates progress on three environmentally adaptive MAM classes: corrosion-protective, anti-icing, and thermal-management absorbers. The electromagnetic loss and impedance-matching fundamentals are first established, then the synergistic mechanisms, design strategies, and characterization protocols for each class are examined against representative material systems and their measured performance. The analysis identifies a shared design logic—multiscale hierarchical architecture, interfacial polarization engineering, and multifunctional phase integration—while distinguishing the divergent protection mechanisms: barrier and passivation effects for corrosion, surface-energy and latent-heat regulation for anti-icing, and phonon–electron transport decoupling for thermal management. Persistent bottlenecks include the trade-off between impedance matching and protective-layer density, the absence of standardized coupled-field test protocols, and the scarcity of long-term salt-spray and thermal-cycling durability data. Future directions are delineated: intelligent self-adaptive absorbers, multiphysics-coupled simulation frameworks, and environmentally benign multifunctional integration. The review provides a theoretical and technical basis for the design, construction, and engineering scale-up of next-generation high-performance absorbers for aerospace, electronic, and marine equipment.